Table 2:

Research results to measure the effect of MDT on liver cancer

Characteristics	MDT cohort, N (%)	Non-MDT cohort, N (%)	P-value
Gender
Male	1080 (13.27)	5205 (63.95)	< 0.001
Female	381 (4.6)	1472 (18.08)	< 0.001
Age
Median years	45.08	54.91	< 0.001
Follow-up
Duration	1599 (47.48)	1769 (52.53)	< 0.001
Mean	199/875	221/125	< 0.001
Post-operative morbidity
Mean (95% CI)	29% (6.2%–34%)	23.5% (15%–32%)	< 0.001
Response to chemotherapy
Mean (95% CI)	64% (48.5%–81.7%)	57.5% (49.4%–88.5%)	< 0.001